A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung

R. G. Crystal, A. Jaffe, S. Brody, A. Mastrangeli, N. G. McElvaney, M. Rosenfeld, C. S. Chu, C. Danel, J. Hay, T. Eissa

Research output: Contribution to journalReview articlepeer-review

62 Scopus citations
Original languageEnglish
Pages (from-to)643-666
Number of pages24
JournalHuman Gene Therapy
Issue number5
StatePublished - 1995

Cite this